Mechanism of action
Dacarbazine is an imidazole carboxamide derivative with structural similarity to certain purines. However, its primary mode of action appears to be alkylation of nucleic acids. Dacarbazine is cell cycle phase-nonspecific.
Dacarbazine belongs to the group of medicines called alkylating agents. It is used to treat cancer of the lymph system and malignant melanoma (a type of skin cancer). It may also be used to treat other kinds of cancer,
Dacarbazine is an imidazole carboxamide derivative with structural similarity to certain purines. However, its primary mode of action appears to be alkylation of nucleic acids. Dacarbazine is cell cycle phase-nonspecific.
Dacarbazine is an imidazole carboxamide derivative with structural similarity to certain purines. However, its primary mode of action appears to be alkylation of nucleic acids. Dacarbazine is cell cycle phase-nonspecific.
© 2025[current_year] The Doctors Platform. All Right Reserved.
© 2025 The Doctors Platform. All Right Reserved.